399 related articles for article (PubMed ID: 34638545)
21. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
[TBL] [Abstract][Full Text] [Related]
22. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis.
Son J; Huang S; Zeng Q; Bricker TL; Case JB; Zhou J; Zang R; Liu Z; Chang X; Darling TL; Xu J; Harastani HH; Chen L; Gomez Castro MF; Zhao Y; Kohio HP; Hou G; Fan B; Niu B; Guo R; Rothlauf PW; Bailey AL; Wang X; Shi PY; Martinez ED; Brody SL; Whelan SPJ; Diamond MS; Boon ACM; Li B; Ding S
mBio; 2022 Feb; 13(1):e0337721. PubMed ID: 35038906
[TBL] [Abstract][Full Text] [Related]
23. Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2.
Chuong C; DuChane CM; Webb EM; Rai P; Marano JM; Bernier CM; Merola JS; Weger-Lucarelli J
Viruses; 2021 May; 13(6):. PubMed ID: 34070524
[TBL] [Abstract][Full Text] [Related]
24. Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants.
Thümmler L; Beckmann N; Sehl C; Soddemann M; Braß P; Bormann M; Brochhagen L; Elsner C; Hoertel N; Cougoule C; Ciesek S; Widera M; Dittmer U; Lindemann M; Horn PA; Witzke O; Kadow S; Kamler M; Gulbins E; Becker KA; Krawczyk A
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675888
[TBL] [Abstract][Full Text] [Related]
25. The
Urda L; Kreuter MH; Drewe J; Boonen G; Butterweck V; Klimkait T
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062310
[TBL] [Abstract][Full Text] [Related]
26. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.
Nguyen LC; Yang D; Nicolaescu V; Best TJ; Gula H; Saxena D; Gabbard JD; Chen SN; Ohtsuki T; Friesen JB; Drayman N; Mohamed A; Dann C; Silva D; Robinson-Mailman L; Valdespino A; Stock L; Suárez E; Jones KA; Azizi SA; Demarco JK; Severson WE; Anderson CD; Millis JM; Dickinson BC; Tay S; Oakes SA; Pauli GF; Palmer KE; ; Meltzer DO; Randall G; Rosner MR
Sci Adv; 2022 Feb; 8(8):eabi6110. PubMed ID: 35050692
[TBL] [Abstract][Full Text] [Related]
27. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
[TBL] [Abstract][Full Text] [Related]
28. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.
Terrier O; Dilly S; Pizzorno A; Chalupska D; Humpolickova J; Bouřa E; Berenbaum F; Quideau S; Lina B; Fève B; Adnet F; Sabbah M; Rosa-Calatrava M; Maréchal V; Henri J; Slama-Schwok A
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946802
[TBL] [Abstract][Full Text] [Related]
29. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
[TBL] [Abstract][Full Text] [Related]
30. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
Mirabelli C; Wotring JW; Zhang CJ; McCarty SM; Fursmidt R; Pretto CD; Qiao Y; Zhang Y; Frum T; Kadambi NS; Amin AT; O'Meara TR; Spence JR; Huang J; Alysandratos KD; Kotton DN; Handelman SK; Wobus CE; Weatherwax KJ; Mashour GA; O'Meara MJ; Chinnaiyan AM; Sexton JZ
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34413211
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.
Raymonda MH; Ciesla JH; Monaghan M; Leach J; Asantewaa G; Smorodintsev-Schiller LA; Lutz MM; Schafer XL; Takimoto T; Dewhurst S; Munger J; Harris IS
Virology; 2022 Jan; 566():60-68. PubMed ID: 34871905
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
[TBL] [Abstract][Full Text] [Related]
33. Aprotinin Inhibits SARS-CoV-2 Replication.
Bojkova D; Bechtel M; McLaughlin KM; McGreig JE; Klann K; Bellinghausen C; Rohde G; Jonigk D; Braubach P; Ciesek S; Münch C; Wass MN; Michaelis M; Cinatl J
Cells; 2020 Oct; 9(11):. PubMed ID: 33143316
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
35. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
36. SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
Pandey K; Acharya A; Pal D; Jain P; Singh K; Durden DL; Kutateladze TG; Deshpande AJ; Byrareddy SN
Antiviral Res; 2024 Jul; 227():105904. PubMed ID: 38729306
[TBL] [Abstract][Full Text] [Related]
37. Antiviral Activity of the Propylamylatin
Brown AN; Strobel G; Hanrahan KC; Sears J
Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
[TBL] [Abstract][Full Text] [Related]
38. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of itraconazole against SARS-CoV-2.
Van Damme E; De Meyer S; Bojkova D; Ciesek S; Cinatl J; De Jonghe S; Jochmans D; Leyssen P; Buyck C; Neyts J; Van Loock M
J Med Virol; 2021 Jul; 93(7):4454-4460. PubMed ID: 33666253
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses.
Fomenko VV; Rudometova NB; Yarovaya OI; Rogachev AD; Fando AA; Zaykovskaya AV; Komarova NI; Shcherbakov DN; Pyankov OV; Pokrovsky AG; Karpenko LI; Maksyutov RA; Salakhutdinov NF
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
